National University of Lesotho Pharmacy Students' Association - NULPSA

04/09/2026

Hello Pharmily

We invite you to a karaoke experience.🥰 *This event is not for pharmacy scholars only,* everybody is invited. So bring your voice,🎉😍 let's turn up the vibes and make this event rememberable

02/09/2026

NULPSA B.PHARM VARSITY JACKET
WEAR THE PROFESSION. REPRESENT THE PRIDE.
Introducing the NULPSA B.Pharm Varsity Jacket — a premium statement piece designed for students who carry the spirit of pharmacy, academic excellence, and the National University of Lesotho wherever they go.
💙 Premium Varsity Design
A timeless navy-blue finish created to give you a polished, confident look.
💊 Proudly Pharmacy
Featuring the official NULPSA Pharmacy identity and B.PHARM designation.
🎓 Built for the B.Pharm Community
More than a jacket — it represents the journey, dedication, friendships, and ambition behind becoming a pharmacist.
🏛️ Represent Your Institution
Wear your university identity with pride and carry the NUL spirit wherever your journey takes you.

30/08/2026

30/08/2026

Concerned about Clinical Pharmacy and all the details it entails? Are you not following in Analytical Chemistry or even Pharmacology. Look no further! Congratulations Maneo Taile level 500. She is here to guide you through! We look forward to working with you🥳

30/08/2026

Level 300? Are you worried about pharmacology and mechanisms of action? Are you not seeing the hybridizations in chemistry? Worry not. Introducing Miss Mpho Moabi. She will be the Level 300 tutor to help facilitate in concepts that are hard to grasp and understand! Congratulations on this journey! We look forward to working with you.🥳

30/08/2026

National University of Lesotho Pharmacy Students' Association - NULPSA invites the alumni, students and other qualified pharmacy professionals to take part in tutoring our students. For interested individuals, please reach out via email or call any number there. Remember, sharing your knowledge makes change. We are looking forward to working with you to better student well-being and provide academic support in our profession

25/08/2026

NUL’s Doctor Poloko Kheoane Studies Formulation and Characterization of liposomes containing drug absorption enhancers for optimized anti-HIV and antimalarial drug delivery
________________________________
Brought to you by NUL Innovation Hub, Where Academia Meets Industry!

Abstract
Most of the current clinically used anti-HIV and antimalarial drugs have low bioavailability, either due to poor solubility and permeability, rapid clearance from anatomical reservoirs and poor retention at their site of action (e.g. due to the p-glycoprotein efflux system), and extreme first-pass metabolism (e.g. by the cytochrome P450 enzymes). Hence, new approaches such as the incorporation of drug absorption enhancers (DAEs) (also referred to as bioenhancers) into dosage forms, and exploration of nanocarriers such as liposomes as novel dosage forms, are needed and may provide a viable means that could improve the bioavailability of both anti-HIV and antimalarial drugs. Liposomes loaded with efavirenz or mefloquine in combination with drug absorption enhancers, as well as placebo dosage forms, were prepared using a thin-lipid film hydration technique and characterized for their particle size and zeta potentials, entrapment efficiency, in vitro drug release, and in vitro drug permeability. Liposomes were further investigated for their biocompatibility (safety) using H-4-II-E liver cells in vitro. Drug-loaded liposomes prepared using l-α-phospatidylcholine, dioleoyl (DOPC) and cholesterol (CHOL) (1:1 mol/mol) as well as liposomes made of 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), CHOL, and 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) (4:6:26 mol/mol/mol) exhibited the best results in terms of their entrapment efficiency, particle size, zeta potential, in vitro drug release, and permeability. DSPC:CHOL:DPPC liposomes released EFV-based formulations better than DPPC:CHOL liposomes for immediate release behaviour. DOPC:CHOL liposomes produced a controlled release and more drug was released in the presence of DAEs for both EFV (0.4-fold higher) and MQ-based (sevenfold higher) formulations in the first 2 h. However, these liposomes were less biocompatible (< 50% cell viability) with liver cells. DOPC:CHOL and DSPC:CHOL:DPPC liposomes could provide a useful nano-formulation platform, which could ensure drug loading, followed by sustained release of both anti-HIV and antimalaria drugs.
______________________________
Kheoane, P. S., Enslin, G. M.-A., & Tarirai, C. (2023). Formulation and characterization of liposomes containing drug absorption enhancers for optimized anti-HIV and antimalarial drug delivery. Drug Delivery and Translational Research, 13(5), 1358–1371. https://doi.org/10.1007/s13346-022-01264-w.

23/08/2026

A NEW CHAPTER. A NEW STANDARD. 💊✨
Congratulations to the newly elected NULPSA Committee—a team entrusted not merely with titles, but with the responsibility to lead, represent, innovate and leave a meaningful mark on Pharmacy.
From the Chairperson to the President, Vice President, Secretary General, Treasurer, Vice Secretary, PRO and Vice PRO, each member brings a distinct strength to a collective vision: turning leadership into impact and ambition into action.
Your appointment is a recognition of your potential; what you do with it will define your legacy. Lead with purpose. Serve with integrity. Collaborate boldly.
The future of Pharmacy is in capable hands. Congratulations, NULPSA leaders—your time to make a difference starts now. 🥂💊
Pholohong Pharmacy Beautez Lusaka Apex Medical University Pharmacy Students Association Lamupharmsa

26/05/2026

NUL’s Professor Maseabata Ramathebane Asses challenges and opportunities of treating breast cancer in Lesotho
________________________________
Brought to you by NUL Innovation Hub, Where Academia Meets Industry!

ABSTRACT

Background: It has been estimated that, more than 60% of the new breast cancer cases and 70% of related deaths will be seen in Low-Middle Income Countries in the coming 20 years. In Lesotho, out of 228 women, 177 had heard about breast cancer while 72.9% had heard of breast cancer screening. Given limited treatment facilities and options in Lesotho, many patients die soon after diagnosis, before they are able to access treatment; to date this cannot be quantified. Another challenge that affects breast cancer management is treatment and travel-related costs, particularly for those not living close to the medical centre. Most patients are coming with advanced disease stage and are sent home for home-based care, some of which could have been prevented with early screening.
Aim: The aim of study is to determine challenges faced by breast cancer patients, the cost to the health system and the opportunities this may bring to the country.
Methods: A quantitative cross-sectional, prospective and retrospective study was conducted on 45 breast cancer patients who were initiated chemotherapy at the only cancer treatment centre in Lesotho; Senkatana oncology clinic located at the Botshabelo complex in Maseru.
Results: The majority of patients were facing challenges of arranging transport to the doctor (83.3%, n=15), of being far from the healthcare facilities even if transportation was available (77.8%, n=14), paying for healthcare (83.3%, n=15), paying for transport (77.8%, n=14) and paying for diagnostic test (88.9%, n=16) in all ages. Majority of patients who presented for care and treatment late faced challenges more than those who presented earlier. Diagnostic and monitoring laboratory test constituted 64.5% of total direct medical costs followed by 24.7 % from chemotherapy.
Conclusion: The challenges faced by breast cancer patients are financial and practical nature and they get higher for patients who presented at advanced stage for care and treatment. In order to improve breast cancer care and treatment outcome at lower costs efforts for breast cancer awareness need to be intensified so that patients presented early at the health centers. In terms of direct medical cost, the largest cost came from the diagnostic and monitoring laboratory tests.
____________________________
Ramathebane, M., et al., (2023). Assessing challenges and opportunities of treating breast cancer in Lesotho. Medical Research Archives. https://doi.org/10.18103/mra.v11i11.4583

25/05/2026

As future healthcare professionals, we recognize that pharmacy plays a vital role in building a healthier Africa through safe medication use, disease prevention, public health advocacy, research, and equitable healthcare access.
A stronger Africa begins with healthier communities, empowered healthcare systems, and united young leaders committed to excellence and service.
Happy African Union Day from the National University of Lesotho Pharmacy Students Association (NULPSA). 💊✨
“Promoting African unity through health, knowledge, and pharmaceutical care.”